Abiraterone Acetate Tablet
Product Images NDC 64980-418

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 64980-418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Abiraterone Figure 1)

The figure shows the Kaplan-Meier Overall Survival Curves in COU-AA-301 using Intent-to-Treat Analysis. The data presented in the table shows the time to death or mortality rate for patients taking Abiaterone acetate and placebo. The Abiaterone acetate group had a higher overall survival rate compared to the placebo group.*

FDA Label Image

Figure 2 (Abiraterone Figure 2)

This appears to be a table with data on subjects without death over a period of months from randomization. The table compares the results of two treatments - Abiraterone acetate and Placebo, with their corresponding subject counts at different time intervals. The data suggests that Abiraterone acetate may be more effective as the number of subjects without death is higher compared to the Placebo group.*

FDA Label Image

Figure 3 (Abiraterone Figure 3)

FDA Label Image

Container Label (Abiraterone Label)

FDA Label Image

Structure (Abiraterone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.